Tirzepatide
GLP-1/GIP agonist
A dual GIP and GLP-1 agonist with strong evidence for glucose control and substantial weight reduction.
Also sold as
Research chemical vendors can't legally label products with the real name, so Tirzepatide often appears under coded SKUs. If you're shopping and see any of these, it's the same compound:
- 2T
- GLP-2
- GLP2
- Branch-2T· Branch Peptides
- Tirz
- Mounjaro (Rx)
- Zepbound (Rx)
Codes shown are for identification only.
Your draw
What it actually is
Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist. It is sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and other labeled indications. The two incretin pathways work together on appetite, glucose-dependent insulin release, glucagon signaling, and metabolic regulation. In obesity trials, higher-dose groups achieved average weight reductions around 20%, though individual response and tolerability vary.
The labeled starting dose is a treatment-initiation dose, not a maintenance target. Nausea, diarrhea, constipation, vomiting, and reduced appetite are common during escalation. Product labeling includes contraindications and warnings that should be reviewed with a clinician.
Why people use it
- Type 2 diabetes treatment with substantial A1C reduction
- Chronic weight management with a higher average trial response than semaglutide in head-to-head research
- Once-weekly dosing and a labeled step-up schedule designed around tolerability
- An approved option for people discussing a dual agonist with their clinician
Educational only · Not a vendor claim
How it works
Combines GIP and GLP-1 receptor activity. Together they influence appetite, glucose-dependent insulin secretion, glucagon response, and metabolic handling of nutrients.
Health benefits
- Substantial A1C reduction in type 2 diabetes trials
- Average weight reduction around 20% at higher studied doses in a major obesity trial
- Improvements in waist circumference and several cardiometabolic markers
- Once-weekly administration
What you'll feel
- Reduced hunger and food preoccupation
- Progressive weight change during escalation and maintenance
- Blood glucose may improve quickly in diabetes
- GI symptoms often cluster around dose increases
Pros
- Approved dual-agonist therapy
- Stronger average weight-loss response than semaglutide in head-to-head obesity research
- Robust diabetes and obesity trial program
- Standardized labeled products
Cons
- GI tolerability still limits some users
- Stopping commonly leads to weight regain
- Can contribute to lean-mass loss without adequate nutrition and resistance training
- Coverage and cost vary
Side effects to know
- Nausea, diarrhea, or constipation
- Vomiting, reflux, or abdominal discomfort
- Reduced appetite and dehydration
- Gallbladder problems and injection-site reactions
- Serious persistent abdominal pain needs urgent evaluation
Best suited for
Educational summary · Not medical advice · Discuss with a qualified clinician
Typical timeline
General pattern for the Fat Loss category. Individual response varies.
- Week 1Titrate up slowly. Expect appetite drop, mild nausea, and possible constipation with GLP-1s. Hydrate and lean on fiber.
- Weeks 2–4Steady weight trend down (0.5–1.5 lb/week is healthy). Prioritize protein (~1 g/lb lean mass) to protect muscle.
- Weeks 4–8Body composition visibly shifts. Add resistance training if you haven't — muscle preservation is the whole game.
- Weeks 8+Re-evaluate dose. Consider a maintenance drop or a scheduled break to reset receptor sensitivity.
Pairs well with
Common combinations experienced users run alongside Tirzepatide. Always add one peptide at a time so you can attribute effects and side effects.
Read the safety guide before stacking.
The reconstitution math
- 1Reconstitute the 10 mg vial with 2 mL of bacteriostatic water. Tilt — don't shake.
- 2Concentration becomes 5,000 mcg/mL (5 mg/mL).
- 3For a 2 mg dose, draw 0.400 mL — that's 40 units on a 1 mL insulin syringe.
- 4One vial gives you approximately 5 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Dose logging is available for signed-in users. Track today's dose and notes for Tirzepatide.
Alert me when Tirzepatide drops in price
We track Branch Peptides pricing every day. Tell us where to reach you and we'll flag the next price drop or restock.
Mixing ratios, units to draw and storage basics — one page, no strings.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.
Keep going from here
Everything on the site that connects to Tirzepatide: comparable compounds, the exact math for this vial, and the tools to run the cycle.
Compare with these
Tools for this protocol
Prefilled with 10 mg, 2 mL BAC water, and a 2 mg dose.
Printable units-to-micrograms lookup for every common vial and water volume.
Add Tirzepatide to a protocol with schedule, dosing, and a shopping list.
Log each dose so you can tie effects and side effects to real dates.
Put Tirzepatide next to two other peptides on dosing and goals.
The full fat loss hub: peptides, stacks, and guides in one place.